Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 811 to 825 of 1688 results for carers

  1. Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]

    In development [GID-TA11267] Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Teclistamab with daratumumab for treating relapsed or refractory multiple myeloma after 1 or more therapies [ID6201]

    Awaiting development [GID-TA11162] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034

      Status ...

    Technology appraisal guidance
    Topic selection

  4. Artificial intelligence software to help detect and characterise colorectal polyps

    In development [GID-DG10118] Expected publication date: TBC

    Diagnostics guidance
    In development

  5. Digital support for children and young people with eating disorders:early value assessment

    Awaiting development [GID-HTE10058] Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  6. Acalabrutinib with venetoclax and obinutuzumab for untreated chronic lymphocytic leukaemia [ID6156]

    Awaiting development [GID-TA11087] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  7. Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235

    In development [GID-TA11246] Expected publication date: TBC

    Technology appraisal guidance
    In development

  8. Hepatocellular carcinoma (unresectable, untreated) - tislelizumab [ID6129]

    Awaiting development [GID-TA11218] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Ambulatory pulmonary artery pressure monitoring devices

    Awaiting development [GID-DG10087] Expected publication date: TBC

    Diagnostics guidance
    Awaiting development

  10. Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer [ID5113]

    Awaiting development [GID-TA11025] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Pembrolizumab for adjuvant treatment of hepatocellular carcinoma [ID3994]

    Awaiting development [GID-TA10895] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Balloon cryoablation for Barrett's oesophagus

    Awaiting development [GID-IPG10413] Expected publication date: TBC

    Interventional procedures guidance
    Awaiting development

  13. Artificial intelligence technologies for mammography: early value assessment

    Awaiting development [GID-HTE10062] Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  14. Virtual Wards for Heart Failure

    Awaiting development [GID-MT609] Expected publication date: TBC

    Medical technologies guidance
    Awaiting development

  15. LATITUDE NXT Patient Management System for monitoring cardiac devices at home (MIB67)

    NICE has developed a medtech innovation briefing (MIB) on the LATITUDE NXT Patient Management System for monitoring cardiac devices at home

    Medtech innovation briefing
    Published
    24 May 2016